Howard said his opponent was a dedicated public servant and a gentleman, and he was honored to have been on the ballot with him. “I am honored to continue to represent the people of the 43rd ...

Amgen (AMGN) announced positive data at 52 weeks in a double-blind, dose-ranging Phase 2 study with MariTide – maridebart cafraglutide, ...

Pfizer has found a successor for retiring Chief Scientific Officer and R&D head Mikael Dolsten, M.D., Ph.D., tapping the ...

Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...

US biotech major Amgen has announced that Dr Howard Chang will join the company as senior vice president of research, ...

Howard Chang, Stanford physician-scientist and biotech co-founder, will become Amgen's new chief science officer.

Amgen (AMGN) announced that Howard Chang will join the company as Senior VP of Research, effective Dec. 16. Chang will also assume the title ...

Amgen on Wednesday said Howard Chang will join the company as senior vice president of research, effective Dec. 16. The company said Chang, who will also serve as chief scientific officer, will ...

FS KKR Capital Corp. today announced that it has completed its previously announced offering of $600 million in aggregate principal amount of its 6.125% unsecured notes due 2030 (the "Notes"). BofA ...

Amgen (NASDAQ:AMGN) today announced that Howard Chang, M.D., Ph.D., will join the company as senior vice president of Research, effective Dec. 16, 2024. Chang will also assume the title and ...

The Mt. Gilead KOA Holiday, owned and operated by Chip and Bambi Hanawalt, has been named Kampgrounds of America, Inc.'s (KOA ...

In a few weeks, Howard Chang, M.D., Ph.D., will join Amgen, filling both the roles of senior vice president of research and ...